Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. We are building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $202.5M
Investors 5
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | Access Bio... | accessbio-... |
| - | OrbiMed | orbimed.co... |
| - | Atlas Vent... | atlasventu... |
| 10.03.2024 | Bain Capit... | baincapita... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 14.02.2023 | - | $62.5M | - |
| 03.09.2021 | Series B | $90M | OrbiMed |
| 30.10.2019 | Series A | $50M | Atlas Vent... |
Mentions in press and media 21
| Date | Title | Description | Source |
| 14.02.2023 | Disc Medicine Announces $62.5 Million Financing led by Bain ... | - | orbimed.co... |
| 14.02.2023 | Disc Medicine Announces $62.5 Million Financing led by Bain ... | - | globenewsw... |
| 20.01.2023 | $412.5 million! Mabwell Announces Exclusive Licensing Agreem... | SAN DIEGO, Jan. 20, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical compan... | en.prnasia... |
| 07.09.2021 | Digital health news, funding roundup in the prior week; Sept... | Whoop raised $200M and acquired PUSH; Cityblock landed $400M; Eight Sleep secured $86M Push: Push is... | vator.tv/n... |
| 04.09.2021 | Daily funding roundup - September 3th, 2021 | Disc Medicine raised $90M; Centaur Labs secured $15M; SimpliFed landed $500K Disc Medicine: Disc Med... | vator.tv/n... |
| 03.09.2021 | The unsexy part of ESG investing | “Esg” sounds more like a noise investors would have made two years ago when hearing the term ESG: Th... | fortune.co... |
| 03.09.2021 | The unsexy part of ESG investing | “Esg” sounds more like a noise investors would have made two years ago when hearing the term ESG: Th... | fortune.co... |
| 03.09.2021 | Disc Medicine Nets $90M Series B Financing | CAMBRIDGE, MA, Disc Medicine, a clinical-stage biotechnology company, announced a $90 million Seri... | vcnewsdail... |
| 02.09.2021 | Blood disorder biotech Disc Medicine gets $90M to bring two ... | The rare diseases called erythropoietic porphyrias (EP) show up in the blood, but patients feel them... | medcitynew... |
| 02.09.2021 | Disc Medicine Announces $90 Million Series B Financing to Ad... | prnewswire... |
Show more